AETHLON MEDICAL INC

AEMD · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus
385
SEC Filings

Business Summary

Aethlon Medical, Inc. is a clinical-stage medical therapeutic company developing the Hemopurifier (HP), a lectin-based immunotherapeutic device designed to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids. The FDA has granted the Hemopurifier Breakthrough Device designation for advanced/metastatic cancer and life-threatening viruses. The company is conducting oncology clinical trials in Australia and pursuing approval in India.

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAEMDdiscussed_in_filing Artificial Intelligence
topic_mentionAEMDdiscussed_in_filing Cybersecurity
topic_mentionAEMDdiscussed_in_filing Trusted Computing
topic_mentionAEMDdiscussed_in_filing Blockchain & Crypto
topic_mentionAEMDdiscussed_in_filing Supply Chain
topic_mentionAEMDdiscussed_in_filing Regulation
topic_mentionAEMDdiscussed_in_filing Automotive
topic_mentionAEMDdiscussed_in_filing Healthcare & Bio
topic_mentionAEMDdiscussed_in_filing AI Compute
topic_mentionAEMDdiscussed_in_filing Platform & Ecosystem
topic_mentionAEMDdiscussed_in_filing Sovereign & Government
topic_mentionAEMDdiscussed_in_filing Artificial Intelligence
topic_mentionAEMDdiscussed_in_filing Cybersecurity
topic_mentionAEMDdiscussed_in_filing Trusted Computing
topic_mentionAEMDdiscussed_in_filing Blockchain & Crypto
topic_mentionAEMDdiscussed_in_filing Supply Chain
topic_mentionAEMDdiscussed_in_filing Regulation
topic_mentionAEMDdiscussed_in_filing Automotive
topic_mentionAEMDdiscussed_in_filing Healthcare & Bio
topic_mentionAEMDdiscussed_in_filing AI Compute

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-06-262025-03-310001683168-25-004780EDGAR76K words
2024-06-272024-03-310001683168-24-004530EDGAR—
2023-06-282023-03-310001683168-23-004487EDGAR—
2022-06-282022-03-310001683168-22-004641EDGAR—
2021-06-242021-03-310001683168-21-002707EDGAR—
2020-06-252020-03-310001683168-20-002070EDGAR—
2019-07-012019-03-310001683168-19-002070EDGAR—
2018-06-082018-03-310001683168-18-001643EDGAR—
2017-06-282017-03-310001683168-17-001671EDGAR—
2016-06-292016-03-310001019687-16-006800EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001683168-26-000964EDGAR19K words
2025-11-122025-09-300001683168-25-008271EDGAR—
2025-08-132025-06-300001683168-25-006049EDGAR—
2025-02-122024-12-310001683168-25-000960EDGAR—
2024-11-132024-09-300001683168-24-007984EDGAR—
2024-08-142024-06-300001683168-24-005708EDGAR—
2024-02-142023-12-310001683168-24-000993EDGAR—
2023-11-142023-09-300001683168-23-008142EDGAR—
2023-08-102023-06-300001683168-23-005524EDGAR—
2023-02-132022-12-310001683168-23-000822EDGAR—
2022-11-142022-09-300001683168-22-007744EDGAR—
2022-08-092022-06-300001683168-22-005474EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001683168-26-001887EDGAR0K words
2026-02-230001683168-26-001259EDGAR—
2026-02-120001683168-26-000959EDGAR—
2026-01-260001683168-26-000528EDGAR—
2025-12-080001683168-25-008953EDGAR—
2025-11-120001683168-25-008257EDGAR—
2025-11-060001683168-25-008001EDGAR—
2025-10-220001683168-25-007719EDGAR—
2025-10-160001683168-25-007586EDGAR—
2025-09-120001683168-25-006917EDGAR—

385 total filings indexed. 353 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc. ATEC — Alphatec Holdings, Inc.

Tags

oncology-(advanced/metastatic-cancer) life-threatening-viral-infections organ-transplantation medical-devices fda-breakthrough-device-designation fda-investigational-device-exemption-(ide) good-manufacturing-practices-(gmp)

Company Identity

CIK0000882291
TickerAEMD
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedNV
HeadquartersSan Diego, California

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9f0a4c5f11b492a1e96e9706ce115278954f9c458722e919b5833eb888f40d43
parent: b5e43f5b6ecfa054109756563f26e7053e68d6bfdb512cdfbb84e58a5d575403
content hash: 64162250b3ca0c99f0b9c00f9974160a5e705329d094a11a92dd6b216396d0f5
signed: 2026-04-13T04:43:29.583Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf